mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.04 |
0.5 |